The 5 most recent market catalysts affecting $NEOG, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 25, 2026
Corporate Catalyst
Neutral
Impact 65
Neogen Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
The filing provides a preview of Neogen's Q1 earnings, scheduled for release on October 6th. Analysts are forecasting a modest increase in EPS from $0.04 to $0.05, but a slight dec…
Aug 26, 2026
Corporate Catalyst
Bullish
Impact 65
Piper Sandler Upgrades Neogen to Overweight, Raises Price Target to $14
Piper Sandler analyst David Westenberg upgraded Neogen (NEOG) from Neutral to Overweight and raised its price target from $13 to $14. This analyst action signals increased confiden…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 75
Neogen shares are trading higher after the company reported better-than-expected Q4 financial results.
This headline indicates a significant positive corporate catalyst for Neogen. Better-than-expected financial results typically lead to increased investor confidence, higher stock p…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 75
Neogen Q4 Adj. EPS $0.09 Beats $(0.07) Estimate, Sales $225.300M Beat $212.355M Estimate
Neogen's significant beat on both adjusted EPS and sales is a strong positive signal for the company and potentially the broader agricultural biotechnology sector. The market often…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.